Hualan Biological Bacterin Inc.

Lot Release Annual Report o f Biological Products i n 2016:   Albumin a nd Coagulation Factor VIII we re Still i n Short Supply In July 4 th   , 2 017,   official website  of   CFDA issued the  Lot Release  Annual Report of Biological Products in 2016, which was compiled by National Institutes for Food and Drug Control. This report was the most authoritative source of data to comprehend the market demand and supply of domestic vaccines and plasma products. Hualan Biological Human Albumin In 2016, release 3949 batches of vaccines and approximately  646 million doses ; 4025 batches  of   plasma  products and approximately  59 . 278 million vial s; 836 batches  of blood screening reagent and about  878 million doses . At present, the lot released vaccine s  and blood screening reagents   are mainly made in China , while the imported products are less than 5 %. As for the plasma  products ,  ...

Hualan Bio Attending the 2017 CPhI Worldwide Exhibition From October 24-26, 2017, 2017 CPhI Worldwide Exhibition was held in Frankfurt. As the leading enterprises in domestic biological pharmaceutical industry, with the support of HulanBiological Engineering Inc . , Hualan Biological Bacterin Co., Ltd. attended the exhibition. Hualan Biological in 2017 CPhI Frankfurt Exhibition In the exhibition, the customers from Columbia, Pakistan, Turkey and other countries showed great interest in our plasma and vaccine products, such as Human Albumin, IVIG , Inactivated Influenza Vaccine (Split virion), Inactivated, Meningococcal Polysaccharide Vaccine Group ACYW135, and etc. which could extend Hualan Bio's oversea business, and most of them were interested to visit Hualan Bio's facilities. For next step, Hualan Bio will strengthen the oversea business cooperation and build a new cooperation platform to all cooperation customers. The Booth of Hualan Biolgocal in 2017 CPHI F...